`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`__________
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC., and AKORN INC.,
`
`Petitioners,
`
`v.
`
`SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC.,
`
`Patent Owners
`
`__________
`
`Case IPR2016-01127 (8,685,930 B2)
`Case IPR2016-01128 (8,629,111 B2)
`Case IPR2016-01129 (8,642,556 B2)
`Case IPR2016-01130 (8,633,162 B2)
`Case IPR2016-01131 (8,648,048 B2)
`Case IPR2016-01132 (9,248,191 B2)
`
`__________
`
`
`
`
`PETITIONER AKORN INC.’S UPDATED MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(3), Petitioner Akorn Inc., hereby files the
`
`
`
`following Updated Mandatory Notices to update the listing of counsel and service
`
`information.
`
`I.
`
`
`
`LEAD AND BACK-UP COUNSEL
`
`Akorn hereby removes Travis Ribar and Azadeh Kokabi as Back- Up
`
`Counsel.
`
`Akorn hereby adds Mark Boland as Back-Up Counsel.
`
`
`
`
`
`II.
`
`SERVICE INFORMATION
`
`Akorn's counsel is listed below.
`
`
`
`LEAD COUNSEL
`Michael Dzwonczyk
`SUGHRUE MION, PLLC
`2100 Pennsylvania Avenue, NW
`Washington, DC 20037
`mdzwonczyk@sughrue.com
`
`
`Please address all correspondence and service to both counsel as listed above.
`
`
`BACK-UP COUNSEL
`Mark Boland
`SUGHRUE MION, PLLC
`2100 Pennsylvania Avenue, NW
`Washington, DC 20037
`mboland@sughrue.com
`
`Respectfully submitted,
`
`Dated: December 27, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Michael Dzwonczyk
`Michael Dzwonczyk
`Lead Counsel for Akorn, Inc.
`Reg. No. 36,787
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`This is to certify that I caused to be served a true and correct copy of the
`
`foregoing Petitioner Akorn Inc.’s Updated Mandatory Notices on this 27th day of
`
`December, 2018, on the Patent Owners at the email addresses of Allergan, Inc.
`
`and St. Regis Mohawk Tribe as follows:
`
`Dorothy P. Whelan
`Michael Kane
`Susan Morrison Colletti
`Robert M. Oakes
`Jonathan Singer
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Email: IPR13351-0008IP1@fr.com
`Email: IPR13351-0008IP2@fr.com
`Email: IPR13351-0008IP3@fr.com
`Email: IPR13351-0008IP4@fr.com
`Email: IPR13351-0008IP5@fr.com
`Email: IPR13351-0008IP6@fr.com
`Email: PTABInbound@fr.com
`
`Alfonso Chan
`Joseph DePumpo
`Michael W. Shore
`Christopher L. Evans
`Shore Chan DePumpo LLP
`901 Main Street, Suite 3300
`Dallas, TX 75201
`Email: achan@shorechan.com
`Email: jdepumpo@shorechan.com
`Email: mshore@shorechan.com
`Email: cevans@shorechan.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`And on the remaining petitioners at the email addresses as follows:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Steven W. Parmelee
`Michael T. Rosato
`Jad A. Mills
`Wendy L. Devine
`Douglas H. Carsten
`Wilson Sonsini Goodrich & Rosati
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Email: sparmelee@wsgr.com
`Email: mrosato@wsgr.com
`Email: jmills@wsgr.com
`Email: wdevine@wsgr.com
`Email: dcarsten@wsgr.com
`Attorneys for Mylan Pharmaceuticals Inc.
`
`
`Gary Speier
`Mark Schuman
`Carlson, Caspers, Vandenburgh, Lindquist &
`Schuman, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Email: gspeier@carlsoncaspers.com
`Email: mschuman@carlsoncaspers.com
`Attorneys for Teva Pharmaceuticals USA, Inc.
`
`Respectfully submitted,
`
`Dated: December 27, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Michael Dzwonczyk
`Michael Dzwonczyk
`Lead Counsel for Akorn, Inc.
`Reg. No. 36,787
`
`